Zevra Therapeutics Inc. (ZVRA): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 25,25 US Dollar | 7 | 2 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 59.383.781 | 10,61 | 6,56 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Zevra Therapeutics Inc.
Mitarbeiter 61
Handelsplatz NASDAQ
Ticker Symbol ZVRA
IPO Datum 2015-04-16
Adresse 101 Federal Street, Boston, MA, United States, 02110
Webseite https://www.zevra.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Neil F. McFarlane | President, CEO & Director |
| 2 | Mr. Rahsaan W. Thompson J.D. | Chief Legal Officer, Secretary & Compliance Officer |
| 3 | Mr. Justin A. Renz CPA, MBA | CFO & Treasurer |
| 4 | Ms. Nichol L. Ochsner | Vice President of Investor Relations & Corporate Communications |
| 5 | Ms. Alison Peters | Chief People Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 8,60% | 52,93 Mio. USD |
| 2 | FMR Inc | 8,28% | 50,93 Mio. USD |
| 3 | Woodline Partners LP | 8,06% | 49,58 Mio. USD |
| 4 | Nantahala Capital Management, LLC | 6,05% | 37,24 Mio. USD |
| 5 | Vanguard Capital Management, LLC | 4,44% | 27,34 Mio. USD |
| 6 | State Street Corp | 2,83% | 17,43 Mio. USD |
| 7 | Geode Capital Management, LLC | 2,59% | 15,96 Mio. USD |
| 8 | D. E. Shaw & Co LP | 2,20% | 13,54 Mio. USD |
| 9 | Qube Research & Technologies | 2,09% | 12,86 Mio. USD |
| 10 | Morgan Stanley - Brokerage Accounts | 2,03% | 12,47 Mio. USD |
| 11 | Legal & General Group PLC | 2,02% | 12,45 Mio. USD |
| 12 | 683 Capital Management LLC | 1,64% | 10,10 Mio. USD |
| 13 | Dimensional Fund Advisors, Inc. | 1,61% | 9,93 Mio. USD |
| 14 | Royce & Associates, LP | 1,49% | 9,15 Mio. USD |
| 15 | Kingdon Capital Management LLC | 1,31% | 8,03 Mio. USD |
| 16 | Jupiter Topco LLC | 1,03% | 6,36 Mio. USD |
| 17 | Retirement Planning Co of New England, Inc. | 1,03% | 6,34 Mio. USD |
| 18 | Arrowstreet Capital Limited Partnership | 1,01% | 6,19 Mio. USD |
| 19 | The Goldman Sachs Group Inc | 0,92% | 5,65 Mio. USD |
| 20 | Vanguard Portfolio Management, LLC | 0,91% | 5,61 Mio. USD |